Education debt is driving medical school graduates away from underserved communities and primary care, both of which our country will sorely need in the coming years.
Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient?